Key findings for this claim are the identification of significant associations between this marker and poor prognosis in multivariable analyses of two patient series, one consisting of 108 cases analyzed as whole sections and the other consisting of 267 TMA-based cases of ER + breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.